These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29072432)

  • 1. Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study.
    Chotivitayatarakorn P; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2839-2843. PubMed ID: 29072432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
    Poonyam P; Chotivitayatarakorn P; Vilaichone RK
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.
    Prapitpaiboon H; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2015; 16(10):4353-6. PubMed ID: 26028098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
    Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
    Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
    Prasertpetmanee S; Mahachai V; Vilaichone RK
    Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
    Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection.
    Wu DC; Kuo CH; Tsay FW; Hsu WH; Chen A; Hsu PI
    Medicine (Baltimore); 2016 Mar; 95(11):e2698. PubMed ID: 26986096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial.
    Bago P; Vcev A; Tomic M; Rozankovic M; Marusić M; Bago J
    Wien Klin Wochenschr; 2007; 119(11-12):372-8. PubMed ID: 17634896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
    Çekin AH; Şahintürk Y; Akbay Harmandar F; Uyar S; Yolcular BO; Çekin Y
    Turk J Gastroenterol; 2017 Jan; 28(1):3-11. PubMed ID: 28007678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
    Myllyluoma E; Veijola L; Ahlroos T; Tynkkynen S; Kankuri E; Vapaatalo H; Rautelin H; Korpela R
    Aliment Pharmacol Ther; 2005 May; 21(10):1263-72. PubMed ID: 15882248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
    Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-controlled triple-blind study.
    Shavakhi A; Tabesh E; Yaghoutkar A; Hashemi H; Tabesh F; Khodadoostan M; Minakari M; Shavakhi S; Gholamrezaei A
    Helicobacter; 2013 Aug; 18(4):280-4. PubMed ID: 23433200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
    Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
    PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
    Gisbert JP; Hermida C; Pajares JM
    Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
    Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand.
    Kongchayanun C; Vilaichone RK; Pornthisarn B; Amornsawadwattana S; Mahachai V
    Helicobacter; 2012 Aug; 17(4):282-5. PubMed ID: 22759328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study].
    Hu FL; Cheng H; Zhang XZ; An HJ; Sheng JQ; Lü NH; Xie Y; Chen ZS; Xu JM; Hu NZ; Zheng PY; Zhang L; Zhang LX; Zhang SS; Tao L; Zhang ZY; Cui MH; Yang GB; Wang BM; Jiang K; Yang Q; Gao HJ
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):679-84. PubMed ID: 22781295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.